A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer

ABSTRACT: This research study is studying a drug as a possible treatment for p53 mutant metastatic colorectal cancer. The drug involved in this study is: -Lamivudine

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2243737 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR